Memgen Announces Addition to Board of Directors
HOUSTON / ACCESSWIRE / April 2, 2020 / Memgen, a private biotechnology company developing innovative immuno-oncology drugs, announced today that Christopher Pagano has joined the company's Board of Directors. "I am delighted to join the board of Memgen at this exciting time in the company's development," noted Mr. Pagano. "Memgen is exploiting leading-edge science to develop novel and effective treatments for cancer patients who currently...
Read more









